Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_assertion type Assertion NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_head.
- NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_assertion description "[JAK2V617F mutation screening is indicated for the evaluation of erythrocytosis, thrombocytosis, splanchnic vein thrombosis, and otherwise unexplained BCR-ABL1-negative granulocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_provenance.
- NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_assertion evidence source_evidence_literature NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_provenance.
- NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_assertion SIO_000772 21723416 NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_provenance.
- NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_assertion wasDerivedFrom befree-20140225 NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_provenance.
- NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_assertion wasGeneratedBy ECO_0000203 NP582323.RA7fS5_vl2haUpNiCCxpZ6oERjPNfo63Da1jXwd0WhnRo130_provenance.